Join to View Full Profile
1505 Northside BoulevardSuite 4300Cumming, GA 30041
Phone+1 770-205-1331
Fax+1 770-205-8727
Dr. Fernando is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2000 - 2003
Duke University HospitalResidency, Internal Medicine, 1997 - 2000
Duke University School of MedicineClass of 1997
Certifications & Licensure
GA State Medical License 2005 - 2027
NC State Medical License 1997 - 2006
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Publications & Presentations
PubMed
- 23 citationsMulticenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancerHanna K. Sanoff, Richard M. Goldberg, Anastasia Ivanova, Seamus O'Reilly, Samer S. Kasbari
Cancer. 2018-08-01 - 8 citationsA phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer.Nan Soon Wong, N. Fernando, Johanna C. Bendell, Michael A. Morse, Gerard C. Blobe
Clinical Colorectal Cancer. 2011-09-01 - 22 citationsA Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal CancerNan Soon Wong, N. Fernando, Andrew B. Nixon, Stephanie M. Cushman, Mebea Aklilu
Anticancer Research. 2011-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










